Buspar (buspirone) and Wellbutrin (bupropion) are not the same medication. They belong to different drug classes, work through different brain chemistry, treat different conditions, and carry different side-effect profiles. The confusion is understandable: the generic names “buspirone” and “bupropion” look and sound almost identical, which has led to real-world prescription mix-ups. But pharmacologically, these two drugs have very little in common.
Why the Names Cause So Much Confusion
The similarity between “buspirone” and “bupropion” is not just a minor resemblance. Both are eight-letter words starting with “bu” and ending in “on,” and they differ by only a few letters in between. This has been flagged repeatedly in pharmacy safety literature as a source of dispensing errors. The Institute for Safe Medication Practices has listed the pair on its list of commonly confused drug names. The brand names help somewhat: Buspar for buspirone and Wellbutrin for bupropion. But since Buspar’s patent expired and its brand-name version was discontinued, most prescriptions are now written generically, making the look-alike problem worse. If you’ve ever wondered whether your pharmacist could accidentally swap one for the other, the answer is yes, it has happened, and it matters because the drugs do very different things.
What Each Drug Is Approved to Treat
Buspirone is an anti-anxiety medication. It is FDA-approved specifically for generalized anxiety disorder. It is not an antidepressant, though it is sometimes added to an antidepressant regimen to boost effects or manage side effects. Buspirone does not work for panic attacks, social anxiety, or the acute relief of anxiety symptoms the way a benzodiazepine would. It requires daily dosing over several weeks before its full effect kicks in.
Bupropion, on the other hand, is primarily an antidepressant. It is FDA-approved for major depressive disorder, seasonal affective disorder, and as a smoking-cessation aid (marketed under the brand name Zyban for that purpose). It also appears in a combination product with naltrexone for weight management. Bupropion is not approved for anxiety and, in some people, can actually worsen anxiety symptoms, especially early in treatment.
How They Work in the Brain
The mechanisms of action are fundamentally different. Buspirone is a partial agonist at serotonin 5-HT1A receptors. In plain terms, it gently activates a specific serotonin receptor subtype that helps regulate anxiety. Research shows that chronic buspirone treatment inhibits serotonin release through these receptors, and that this sustained effect is associated with its anxiety-reducing action over weeks of use.1PubMed. Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration Buspirone does not affect the GABA system, which is the pathway that benzodiazepines use, and that distinction is important for understanding why buspirone is not sedating and not addictive.
Bupropion works through an entirely different set of brain chemicals. It inhibits the reuptake of norepinephrine and dopamine, meaning it keeps more of these two neurotransmitters available in the brain. It has no clinically meaningful effect on serotonin.2PubMed Central. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor This makes bupropion unique among antidepressants, most of which target serotonin to some degree. Its dopamine activity is also likely why it helps with smoking cessation and why it tends to be more activating and energizing than other antidepressants.
So one drug acts on serotonin receptors to reduce anxiety, while the other boosts norepinephrine and dopamine to treat depression. They are working on almost completely non-overlapping neurochemical systems.
Side Effects Compared
Because they act on different pathways, their side-effect profiles are quite distinct.
Buspirone’s most common side effects are dizziness, constipation, and stomach discomfort. A systematic review and meta-analysis found that people taking buspirone were roughly four to five times more likely than those on placebo to experience dizziness, about four times more likely to report constipation, and about twice as likely to have gastric distress.3PubMed Central. Side effects and cognitive benefits of buspirone: A systematic review and meta-analysis Those sound like high numbers, but the absolute rates tend to be modest. Buspirone is generally considered one of the more tolerable medications in psychiatric practice. It does not cause significant sedation, weight gain, or the emotional blunting that some people experience with SSRIs.
Bupropion’s common side effects include dry mouth, insomnia, agitation, anxiety, tremor, gastrointestinal issues, and palpitations. The most serious risk is dose-related seizures.4PubMed Central. Bupropion (Zyban, Wellbutrin SR): reports of deaths, seizures, serum sickness The seizure risk is why bupropion has a maximum recommended dose and why it is contraindicated in people with eating disorders like bulimia, since purging behaviors can alter electrolyte levels and lower the seizure threshold. The insomnia and activating quality of bupropion are essentially the flip side of its dopamine and norepinephrine activity: the same brain stimulation that lifts depression can also make it hard to sleep or make someone feel jittery.
One practical way to think about the difference: buspirone tends to calm people down, while bupropion tends to rev people up. If someone has depression with low energy and poor motivation, bupropion’s activating profile can be helpful. If someone has generalized anxiety with constant worry and tension, buspirone’s calming profile is what they need. Getting the wrong one could make things worse.
Sexual Side Effects and Why Both Get Mentioned
One area where buspirone and bupropion share a reputation is in their favorable effect on sexual function compared to SSRIs. Both are frequently discussed as alternatives or add-ons when SSRI-related sexual dysfunction becomes a problem, but they address it differently.
Bupropion’s advantage is straightforward: because it does not affect serotonin, it largely avoids the sexual side effects that plague SSRIs and SNRIs. Low libido, difficulty with arousal, and delayed or absent orgasm are among the most common complaints with serotonin-targeting antidepressants, and switching to bupropion often resolves them. For this reason, bupropion is a go-to alternative for people who respond to antidepressants but cannot tolerate the sexual side effects.
Buspirone’s role is a bit different. It is sometimes added to an existing SSRI regimen specifically to counteract sexual dysfunction without stopping the SSRI. Case reports have documented resolution of SSRI-induced sexual dysfunction after adding buspirone.5PubMed Central. Improvement in Selective Serotonin Reuptake Inhibitor-Associated Sexual Dysfunction With Buspirone: Examining the Evidence The mechanism is thought to involve buspirone’s action on serotonin 5-HT1A receptors, which may counterbalance the serotonin overactivity that causes the problem in the first place.
Interestingly, when buspirone and bupropion were directly compared for treating low sexual desire in women, a randomized trial found no significant difference between the two after six months of treatment. Neither group showed dramatically improved results over the other in terms of sexual desire or frequency of sexual encounters.6International Journal of Family & Community Medicine. Comparison of the effectiveness of bupropion versus buspirone in the treatment of hypoactive sexual desire in women, a randomized clinical trial This is a single trial and not the final word on the topic, but it suggests the two drugs may be more similar in this narrow context than their different mechanisms would predict.
Addiction Potential and Controlled Substance Status
Neither buspirone nor bupropion is a controlled substance in the United States, and neither is considered to have significant abuse potential. This is worth highlighting because buspirone was developed in part as a safer alternative to benzodiazepines, which are Schedule IV controlled substances due to their dependence liability. Early research confirmed that buspirone appears to lack abuse liability and does not lead to drug dependence or withdrawal symptoms.7PubMed. Assessing the potential for buspirone dependence or abuse and effects of its withdrawal
Bupropion is also non-addictive in the clinical sense, though stopping it abruptly is a different story, as covered in the next section. Neither drug produces the euphoria, sedation, or rapid onset of action that characterizes drugs with high abuse potential. For patients or prescribers concerned about dependence risk, both buspirone and bupropion represent relatively safe options in their respective categories.
What Happens When You Stop Taking Them
Buspirone can generally be stopped without a taper in many cases, though gradual reduction is still considered good practice. The research on buspirone withdrawal consistently finds minimal to no withdrawal syndrome, which is one of its key advantages over benzodiazepines.7PubMed. Assessing the potential for buspirone dependence or abuse and effects of its withdrawal People may experience a return of their underlying anxiety symptoms when they stop, but that is not the same as withdrawal.
Bupropion discontinuation is less clean. Abrupt cessation has been associated with irritable mood, anxiety, sleeplessness, headache, and generalized body aches. A case report documented these symptoms in a patient who stopped bupropion suddenly while being treated for nicotine dependence, and the authors recommended a slow taper for anyone discontinuing the drug.8PubMed Central. Bupropion-Associated Withdrawal Symptoms: A Case Report Bupropion’s withdrawal profile is generally considered milder than that of SSRIs or SNRIs, but it is not zero. If you are on bupropion and want to stop, work with your prescriber to step down the dose gradually.
Off-Label Uses That Add to the Confusion
Part of the reason people confuse these two drugs is that both get prescribed off-label for conditions beyond their FDA approvals, and the off-label uses sometimes overlap in clinical conversations.
Bupropion has been studied as a treatment for ADHD in adults. A Cochrane review of the evidence found that bupropion reduced ADHD symptom severity and increased the proportion of participants achieving clinical improvement compared to placebo, though the evidence was rated as low quality.9PubMed Central. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults This makes bupropion a sometimes-considered option for adults who have both depression and ADHD, or for those who cannot tolerate stimulant medications. Its dopamine and norepinephrine activity gives it a pharmacological rationale for ADHD treatment, even though it is not as potent as dedicated stimulants.
Buspirone, meanwhile, is sometimes prescribed off-label as an augmenting agent for depression when SSRIs alone are insufficient. It has also been explored for social anxiety, PTSD-related anxiety, and behavioral agitation in certain neurological conditions. Because buspirone and bupropion are both used as “add-on” medications in depression treatment, a prescriber might mention both in the same conversation, reinforcing the perception that they are interchangeable. They are not.
Can You Take Both at the Same Time?
Yes, buspirone and bupropion are sometimes prescribed together. Because they work on different neurotransmitter systems, they do not compete pharmacologically, and combining them does not create the dangerous serotonin-syndrome risk that comes with combining two serotonin-active drugs. A clinician might combine them when a patient has both depression and anxiety, using bupropion as the antidepressant and buspirone to address the anxiety that bupropion alone may not help or could even worsen.
That said, both drugs are metabolized through some of the same liver enzyme pathways, so there can be interactions affecting drug levels. Anyone taking both should have their prescriber aware of the combination. The approach is not uncommon in clinical practice, but it is not something to try by mixing leftover prescriptions on your own.
Onset and Dosing Patterns
Both buspirone and bupropion share one inconvenient feature: neither works immediately. Buspirone typically requires two to four weeks of consistent daily dosing before its anti-anxiety effects become apparent. This is a major source of frustration for patients who are used to the rapid relief of benzodiazepines. People sometimes conclude that buspirone “doesn’t work” and stop taking it before it has had time to build up in their system.
Bupropion also takes several weeks to reach full antidepressant effect, which is typical of most antidepressants. The sustained-release and extended-release formulations (Wellbutrin SR and Wellbutrin XL) allow for once- or twice-daily dosing, while the immediate-release form is taken three times a day. The extended-release version is the most commonly prescribed because it keeps blood levels steady and may lower the seizure risk associated with peak-and-trough dosing patterns.
Buspirone is usually dosed two to three times per day as well, since its half-life is relatively short. Neither drug is a take-it-when-you-need-it medication. Both require a commitment to daily use, which is a meaningful similarity despite all their differences.
How Prescribers Choose Between Them
The choice between buspirone and bupropion is rarely an either-or decision, because they treat different primary problems. A person whose main issue is generalized anxiety would be a candidate for buspirone. A person whose main issue is depression would be a candidate for bupropion. The overlap happens when someone has both conditions, which is extremely common: anxiety and depression co-occur frequently, and many patients end up on medications targeting each.
Where things get interesting is in the context of a patient already on an SSRI. If the SSRI is helping with mood but causing sexual side effects or weight gain, bupropion might be added or substituted. If the SSRI is helping with mood but not fully controlling anxiety, buspirone might be added. If the SSRI is causing sexual side effects and the patient also has residual anxiety, both might be added. The pharmacological logic is coherent in each scenario because the two drugs complement different gaps.
For patients who cannot tolerate serotonin-active drugs at all, bupropion becomes one of the few antidepressant options that avoids serotonin entirely. Buspirone’s serotonin activity is receptor-specific and partial, so it is generally tolerated even by people who react badly to SSRIs, but the situations where someone would need one versus the other are driven by the primary diagnosis, not by a head-to-head comparison between the two.
When a Pharmacy Mix-Up Could Be Dangerous
Given everything above, you can see why getting one drug when you were prescribed the other is not a harmless mistake. Someone with generalized anxiety who receives bupropion instead of buspirone could experience worsened anxiety, insomnia, and agitation. Someone with depression who receives buspirone instead of bupropion would get no antidepressant effect and might deteriorate. Beyond the wrong therapeutic effect, a patient with a seizure history who inadvertently receives bupropion could face real danger, since bupropion’s seizure risk does not apply to buspirone at all.
If you are picking up a prescription for either drug, verify the generic name on the label, not just the number of pills. If the label says “buspirone” and you expected bupropion, or vice versa, call your prescriber before taking it. Pharmacies increasingly use tall-man lettering (busPIRone vs buPROPion) to reduce these errors, but patients serve as the last safety check. Knowing that these are two completely different medications with different purposes and different risks puts you in a much better position to catch a mistake before it matters.